Financials
- Market Capitalization 55.3 M
- Employee 21
- Founded 2015
- CEO N/A
- Website www.inmunebio.com
- Headquarter Nevada, United States
- FIGI BBG00LW94L98
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.69
売上高対価格比率
—
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4250 | BOLD Boundless Bio, Inc. - Common Stock | 2.45 USD | -0.41% | -1.21% | +71.33% | +111.21% | 55.04 M USD | ||
| 4253 | BYSI BeyondSpring, Inc. - Ordinary Shares | 1.43 USD | +7.52% | -12.80% | -11.18% | -37.00% | 58.80 M USD | ||
| 4266 | TIL Instil Bio, Inc. - Common Stock | 7.66 USD | -2.05% | -1.42% | -2.67% | -60.70% | 51.95 M USD | ||
| 4272 | XLO Xilio Therapeutics, Inc. - Common Stock | 9.01 USD | -0.22% | -3.94% | +6.00% | +1134.25% | 52.10 M USD |